Great Point Partners’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-292,673
Closed -$3.73M 41
2017
Q4
$3.73M Buy
+292,673
New +$3.73M 0.64% 31